» Authors » A Luger

A Luger

Explore the profile of A Luger including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 284
Citations 1425
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Luger A, Broersen L, Biermasz N, Biller B, Buchfelder M, Chanson P, et al.
Eur J Endocrinol . 2021 Aug; 185(3):G1-G33. PMID: 34425558
Pregnancies are rare in women with pituitary adenomas, which may relate to hormone excess from secretory subtypes such as prolactinomas or corticotroph adenomas. Decreased fertility may also result from pituitary...
2.
Resl M, Vila G, Heinzl M, Luger A, Neuhold S, Prager R, et al.
J Diabetes Complications . 2021 Jul; 35(9):107990. PMID: 34294516
Background: Based on the complex pathophysiology of type 2 diabetes and atherosclerosis we hypothesized a dynamic change in prognostic value of cardiovascular biomarkers over time. Methods: In this prospective study...
3.
Muller M, Beiglbock H, Fellinger P, Winhofer Y, Luger A, Gschwandtner M, et al.
J Endocrinol Invest . 2020 Jun; 44(2):339-345. PMID: 32488723
Background: Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, patients suffering from primary adrenal insufficiency (AI) have an increased mortality, mainly due to cardiovascular diseases. Only little knowledge exists...
4.
Ivanenko Y, Nedic M, Gustafsson M, Jonsson B, Luger A, Nordebo S
R Soc Open Sci . 2020 Mar; 7(1):191541. PMID: 32218971
We introduce the set of quasi-Herglotz functions and demonstrate that it has properties useful in the modelling of non-passive systems. The linear space of quasi-Herglotz functions constitutes a natural extension...
5.
Schernthaner-Reiter M, Itariu B, Krebs M, Promintzer-Schifferl M, Stulnig T, Tura A, et al.
Nutr Metab Cardiovasc Dis . 2019 Feb; 29(4):334-342. PMID: 30718144
Background And Aims: Growth differentiation factor 15 (GDF15) is a strong predictor of cardiovascular morbidity and mortality found to be both marker and target of impaired glucose metabolism. GDF15 increases...
6.
Petersenn S, Christ-Crain M, Droste M, Finke R, Flitsch J, Kreitschmann-Andermahr I, et al.
Internist (Berl) . 2017 Oct; 58(11):1171-1182. PMID: 29027568
Acromegaly is a rare and severe condition, presenting with typical signs and symptoms. The diagnosis is often initially made years after the first manifestations of the disease. In more than...
7.
Steinkohl F, Luger A, Bektic J, Aigner F
Radiologe . 2017 Jul; 57(8):615-620. PMID: 28702693
Background: Prostate cancer is the most frequent cancer in men. The diagnosis is normally achieved by a systematic prostate biopsy; however, this is a randomized approach by which a substantial...
8.
Resl M, Clodi M, Vila G, Luger A, Neuhold S, Wurm R, et al.
Heart . 2016 Jul; 102(24):1963-1968. PMID: 27456261
Objective: We hypothesised that biomarkers representing different pathophysiological pathways of atherosclerosis namely growth differentiation factor 15 (GDF-15), N-terminal pro B-type natriuretic peptide (NT-proBNP) and high-sensitive troponin T (hs-TnT) could enhance...
9.
Wolf P, Winhofer Y, Krssak M, Smajis S, Harreiter J, Kosi-Trebotic L, et al.
Nutr Metab Cardiovasc Dis . 2016 Apr; 26(5):387-92. PMID: 27118107
Background And Aim: Type 2 diabetes (T2DM) is closely associated with the development of heart failure, which might be related with impaired substrate metabolism and accumulation of myocardial lipids (MYCL)....
10.
Schernthaner-Reiter M, Kiefer F, Zeyda M, Stulnig T, Luger A, Vila G
Int J Obes (Lond) . 2015 Mar; 39(7):1143-50. PMID: 25809829
Objective: The serum- and glucocorticoid-regulated kinase 1 (SGK1) is an early transcriptional target of glucocorticoids and is activated via insulin. Here we investigate the regulation of SGK1 expression in human...